Search

everythinglearnresearchcommunity

for

Search:↓

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

Two new compounds were found to effectively reduce hair growth in mice.

Minoxidil may protect the brain from damage by preventing cell death and energy loss.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

MK-386 lowers DHT in blood and skin but not in semen.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Minoxidil stops cells from making prostacyclin, which may help with hair growth. More research is needed.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Applying a specific inhibitor lightens skin and hair color.

Some gonadal hormone drugs can block filovirus entry into cells.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Minoxidil reduces lysine hydroxylase in skin cells.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.